Wulff, Hansen & Co’s Eli Lilly LLY Stock Holding History

Wulff, Hansen & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$510K	Hold	555	–	–	0.52%	57
2025 Q4	$596K	Hold	555	–	–	0.5%	54
2025 Q3	$423K	Sell	555 -230	-29%	-$171K	0.36%	68
2025 Q2	$612K	Hold	785	–	–	0.52%	54
2025 Q1	$648K	Hold	785	–	–	0.59%	51
2024 Q4	$606K	Hold	785	–	–	0.57%	48
2024 Q3	$695K	Sell	785 -250	-24%	-$225K	0.63%	48
2024 Q2	$937K	Hold	1,035	–	–	0.93%	40
2024 Q1	$805K	Hold	1,035	–	–	0.8%	41
2023 Q4	$603K	Hold	1,035	–	–	0.67%	45
2023 Q3	$556K	Sell	1,035 -850	-45%	-$438K	0.65%	46
2023 Q2	$884K	Hold	1,885	–	–	0.99%	33
2023 Q1	$647K	Buy	+1,885	New	+$636K	0.74%	46

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wulff, Hansen & Co's LLY Position: Q1 2026 in Review

Wulff, Hansen & Co held its Eli Lilly (LLY) position steady in Q1 2026 at 555 shares worth $510K. The position accounts for 0.52% of the portfolio, ranked #57.

Wulff, Hansen & Co first reported a position in LLY in Q1 2023 and has held it in 13 quarters since. The position peaked at $937K in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Wulff, Hansen & Co held 555 shares of Eli Lilly worth $510K as of Q1 2026.
Wulff, Hansen & Co left its Eli Lilly share count unchanged in Q1 2026.
Eli Lilly made up 0.52% of Wulff, Hansen & Co's portfolio in Q1 2026, its #57 holding.
Wulff, Hansen & Co first reported a position in Eli Lilly in Q1 2023 and has held it in 13 quarters since.
Wulff, Hansen & Co's Eli Lilly position peaked at $937K in Q2 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wulff, Hansen & Co's 13F filing for Q1 2026, filed 7 May 2026.